CMEA Capital

Industry Venture Capital
Founded 1989
Headquarters San Francisco, California, United States
Key people
 Jim Watson, Karl Handelsman, Faysal Sohail, David Collier
Website www.cmea.com

CMEA Capital is a venture capital firm located in San Francisco, California. The firm was founded by Tom Baruch with New Enterprises Associates in 1989 as a $40M fund entitled “Chemical and Materials Enterprise Associates”.

History

CMEA’s early focus was on investing in startup enterprises that commercialized new applications of specialty chemicals and materials technologies. Twenty-one years later, CMEA Capital has raised six additional funds [1][2] and currently has $1.1 billion under management. CMEA Capital provides capital to entrepreneurs in the energy and materials,[3] information technology,[4] and life science[5] sectors.

The company has been an investor in more than 120 energy & materials, information technology and life sciences companies over the past twenty one years including: Aclara Biosciences (which merged with Monogram Biosciences,[6] Biomimetic Therapeutics, Cadabra Design Automation (acquired by Synopsys[7]), Everest Design Automation (acquired by Synopsys[8]).

Tom Baurch retired from the firm in 2010.

References

  1. ↑ "CMEA Ventures raises $300 million fund". San Francisco Business Times. 2004-09-20. Retrieved 2010-07-02.
  2. ↑ "CMEA Ventures raises $400 million in its seventh fund". San Francisco Business Times. 2008-03-27. Retrieved 2010-07-02.
  3. ↑ "Portfolio Companies: Energy & Materials". CMEA. Retrieved 2013-08-15.
  4. ↑ "Portfolio Companies: Information Technology". CMEA. Retrieved 2013-08-15.
  5. ↑ "Portfolio Companies: Life Sciences". CMEA. Retrieved 2013-08-15.
  6. ↑ "ViroLogic to buy Aclara". San Jose Business Journal. 2004-06-01. Retrieved 2010-07-02.
  7. ↑ "Cadabra Automates the Creation of Standard Cell Layouts". Synopsis.com. Retrieved 2010-07-02.
  8. ↑ "Synopsys Acquires Everest Design Automation". All Business. Retrieved 2010-07-02.

External links